Using the Antinuclear Antibody Test to Diagnose Rheumatic Diseases

2012 ◽  
Vol 105 (2) ◽  
pp. 100-104 ◽  
Author(s):  
Elizabeth R. Volkmann ◽  
Mihaela Taylor ◽  
Ami Ben-Artzi
Keyword(s):  
Rheumatic Diseases ◽  
Antinuclear Antibody ◽  
Antibody Test

Guidelines for Clinical Use of the Antinuclear Antibody Test and Tests for Specific Autoantibodies to Nuclear Antigens

2000 ◽  
Vol 124 (1) ◽  
pp. 71-81 ◽  
Author(s):  
Arthur Kavanaugh ◽  
Russell Tomar ◽  
John Reveille ◽  
Daniel H. Solomon ◽  
Henry A. Homburger
Keyword(s):  
Rheumatic Diseases ◽  
Lupus Erythematosus ◽  
Antinuclear Antibody ◽  
Clinical Decision Making ◽  
Antibody Test ◽  
Disease Diagnosis ◽  
Test Results ◽  
Appropriate Use ◽  
Nuclear Antigens ◽  
Systemic Rheumatic Diseases

Abstract The following guideline presents a series of recommendations based on published medical literature for use of the antinuclear antibody (ANA) test and tests for specific autoantibodies to nuclear antigens in the diagnostic evaluation, prognostic assessment, and monitoring of patients with systemic rheumatic diseases. The guideline emphasizes the need for clinical evaluation to improve the usefulness of test results in patient management. Consideration is given to appropriate use of the generic ANA test in the initial evaluation of patients with signs and symptoms of a systemic rheumatic disease, the evaluation of patients suspected of having lupus erythematosus, use in clinical situations in which the ANA test is required to establish a disease diagnosis, and identification of clinical situations in which the ANA test has little value. Sections are also devoted to recommendations aimed at improving the analytic methods used to detect and measure ANA and specific autoantibodies to nuclear antigens and to the appropriate use of tests for specific autoantibodies in several disease situations that commonly occur in patients with suspected or documented systemic rheumatic diseases. Emphasis is placed on the use of these tests only in situations in which the test results can be expected to provide information necessary for clinical decision making. Those tests of limited medical usefulness and situations in which test results are likely to be misleading are also identified.

Antinuclear antibody profiles in rheumatic diseases

1987 ◽  
Vol 8 (11) ◽  
pp. 168-171
Author(s):  
B. Kohleisen ◽  
I. Kalies ◽  
K. Koelble ◽  
J.R. Kalden
Keyword(s):  
Rheumatic Diseases ◽  
Antinuclear Antibody

The Antinuclear Antibody Test

1981 ◽  
Vol 70 (3) ◽  
pp. 197-198
Author(s):  
Helene Paxton
Keyword(s):  
Antinuclear Antibody ◽  
Antibody Test

When to order an antinuclear antibody test

BMJ ◽  
2013 ◽  
Vol 347 (aug21 2) ◽  
pp. f5060-f5060 ◽  
Author(s):  
A. Binder ◽  
S. Ellis
Keyword(s):  
Antinuclear Antibody ◽  
Antibody Test

scholarly journals Pattern of antinuclear antibody and antiextractable nuclear antigen antibody test requisitions in Riyadh

2019 ◽  
Vol 8 (11) ◽  
pp. 3559
Author(s):  
NajlaAli Alghabban ◽  
Zahid Shakoor
Keyword(s):  
Antinuclear Antibody ◽  
Antibody Test ◽  
Nuclear Antigen ◽  
Antigen Antibody

scholarly journals The antinuclear antibody test: Last or lasting gasp?

2010 ◽  
Vol 63 (1) ◽  
pp. 19-22 ◽  
Author(s):  
Marvin J. Fritzler
Keyword(s):  
Antinuclear Antibody ◽  
Antibody Test

scholarly journals Review for the generalist: The antinuclear antibody test in children-When to use it and what to do with a positive titer

2010 ◽  
Vol 8 (1) ◽  
pp. 27 ◽  
Author(s):  
Peter N Malleson ◽  
Murray J Mackinnon ◽  
Michaela Sailer-Hoeck ◽  
Charles H Spencer
Keyword(s):  
Antinuclear Antibody ◽  
Antibody Test
Sign in / Sign up

Export Citation Format

Share Document